This protocol describes simultaneous measurement of electroretinogram and visual evoked potentials in anesthetized rats.
The electroretinogram (ERG) and visual evoked potential (VEP) are commonly used to assess the integrity of the visual pathway. The ERG measures the electrical responses of the retina to light stimulation, while the VEP measures the corresponding functional integrity of the visual pathways from the retina to the primary visual cortex following the same light event. The ERG waveform can be broken down into components that reflect responses from different retinal neuronal and glial cell classes. The early components of the VEP waveform represent the integrity of the optic nerve and higher cortical centers. These recordings can be conducted in isolation or together, depending on the application. The methodology described in this paper allows simultaneous assessment of retinal and cortical visual evoked electrophysiology from both eyes and both hemispheres. This is a useful way to more comprehensively assess retinal function and the upstream effects that changes in retinal function can have on visual evoked cortical function.
Measurement of the electroretinogram (ERG) and visual evoked potential (VEP) provide useful quantitative assessments of the integrity of the visual pathway. The ERG measures the electrical responses of the retina to light stimulation, while the VEP measures the corresponding functional integrity of the visual pathways from the retina to the primary visual cortex following the same light event. This manuscript describes a protocol for the recording and analysis of ERG and VEP responses in a commonly used laboratory model, the rat.
The ERG provides an index of the functional integrity of a number of key retinal cell classes by quantifying the retina's gross electrical response to a flash of light. A coordinated series of ionic fluxes initiated by light onset and offset, produce detectable changes in voltage that can be measured using surface electrodes placed outside the eye. The resultant waveform represents the combination of a series of well-defined components, differing in amplitude, timing and frequency. A substantial body of research has shown that these components are relatively well conserved across many vertebrate retinae and that the components can be separated from each other. By judiciously selecting the stimulus (flash stimulus, background, interstimulus interval) conditions and choosing specific features of the composite waveform to analyze one can be confident of returning a measure of a specific group of retinal cells1,2. These characteristics underlie the utility and hence the widespread applications of the ERG as a non-invasive measure of retina function. This manuscript focuses on the methodology for measuring the ERG and analyzing its features to return information about some of the major cell classes in the retina, namely photoreceptors (the PIII component), bipolar cells (the PII component) and retinal ganglion cells (the positive scotopic threshold response or pSTR).
The VEP provides an assay of the cortical response to light; first originating from the retina and thereafter communicated serially via the optic nerve, optic tract, thalamus (lateral geniculate nucleus, LGN) and optic radiation to area V1 of the cortex3. In rodents, the majority (90 – 95%) of optic nerve fibers from each eye decussate4 and innervate the contralateral mid-brain. Unlike the ERG, it is as yet not possible to attribute different components of the VEP to specific cell classes,5 thus changes anywhere along the visual pathway could affect the VEP waveform. Nevertheless, the VEP is a useful non-invasive measure of visual performance and visual pathway integrity. The VEP, when used in conjunction with the ERG, can provide a more complete assessment of the visual system (i.e., retina/visual pathway).
ERG and VEP recordings can be conducted in isolation or in combination, depending on the application. The methodology described in this paper allows simultaneous assessment of retinal and cortical visual evoked electrophysiology from both eyes and both hemispheres in anesthetized rats. This is a useful way to more comprehensively assess retinal function and the upstream effects that changes in retinal function can have on visual evoked cortical function.
All experimental procedures were conducted according to the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes, set out by the National Health and Medical Research Council in Australia. Ethics clearance was obtained from the University of Melbourne, Science Faculty, Animal Ethics Committee (approval number 0911322.1).
1. Pre-implantation of Chronic VEP Electrodes
Note: If concurrent ERG and VEP signals are to be collected animals must be surgically implanted with VEP electrodes at least 1 week prior to signal collection.
2. ERG and VEP Recording
Waveform | Stimulus light energy (log cd.s.m-2) | Number of repeats | interstimulus interval (sec) |
STR | -6.24 | 20 | 2 |
STR | -5.93 | 20 | 2 |
STR | -5.6 | 20 | 2 |
STR | -5.33 | 20 | 2 |
Rod b-wave | -4.99 | 10 | 2 |
Rod b-wave | -4.55 | 10 | 2 |
Rod b-wave | -4.06 | 5 | 5 |
Rod b-wave | -3.51 | 5 | 5 |
Rod b-wave | -3.03 | 1 | 15 |
Rod b-wave | -2.6 | 1 | 15 |
Rod b-wave | -1.98 | 1 | 15 |
Mixed a-/b-wave | -1.38 | 1 | 30 |
Mixed a-/b-wave | -0.94 | 1 | 30 |
Flash 1: Mixed a-/b-wave Average of 20: VEP | -0.52 | 20 | 5 |
(90 sec before next) | |||
Flash 1: Mixed a-/b-wave Average of 20: VEP | 0.04 | 20 | 5 |
(120 sec before next) | |||
Flash 1: Mixed a-/b-wave Average of 20: VEP | 0.58 | 20 | 5 |
(180 sec before next) | |||
Flash 1: Mixed a-/b-wave Average of 20: VEP | 1.2 | 20 | 5 |
(180 sec before next) | |||
Flash 1: Mixed a-/b-wave Average of 20: VEP | 1.52 | 20 | 5 |
(180 sec before next) | |||
Cone a-/b-wave | 1.52 | 4 | 0.5 |
Table 1. ERG and VEP Recording Protocol Using a Range of Stimulus Energy. Stimulus presentations progress from dim (top) to bright (bottom) flashes, with sufficient inter-stimulus interval to ensure dark adaption. At the end of protocol, repetition of four flashes with short interval is presented to elicit the cone mediated response.
3. Analysis of ERG Waveforms
Note: ERG and VEP analysis has been described in detail previously.3,9,10 The following sections provide a brief overview.
4. Analysis of VEP Waveforms
The ERG a-wave (> -1.38 log cd.s.m-2), b-waves (> – 4.99 log cd.s.m-2) STRs (< – 4.99 log cd.s.m-2) and the VEPs (> – 0.52 log cd.s.m-2) were recorded simultaneously (Figure 1 and 3). At very dim flashes, a positive STR (pSTR) is seen at approximately 110 msec after the flash, and a negative STR (nSTR) at approximately 220 msec (Figures 1 and 2). An ERG with a large b-wave, peaks between 50 to 100 msec after the onset of a moderate flash which can be analyzed for its PII response (Figures 1 and 2). At this stimulus energy, the negative a-wave before the peak is negligible. At brighter luminous energies the negative deflection a-wave becomes more prominent which can be quantified with the PIII response (Figure 2). The scotopic VEP waveform shows a negative response (P1N1; 15 – 70 msec window) followed by a positive deflection (N1P2; 30 – 100 msec) (Figures 3 and 4).
Figure 1. Group Average ERG Waveforms. The ERG alters with increasing stimulus intensity. Numbers to the left of waveform indicate the luminous exposure used to elicit the waveform. Note the different amplitude and time scales for each panel. At dimmer luminous energies the positive and negative components of the scotopic threshold response can be elicited (pSTR, nSTR). As stimulus energies get brighter, the a and b-wave response can be assayed, and a paired-flash paradigm allows the cone response to be measured. Please click here to view a larger version of this figure.
Figure 2. ERG analysis. (A) Rod photoreceptor function can be assayed by using a PIII to model the a-wave. A-waves at 1.22 and 1.52 log cd.s.m-2 (unfilled circles, ○) are fit as an ensemble with a PIII (grey lines, Equation 1) to 90% of the minimum which returns RmPIII (saturated amplitude, µV) S (sensitivity, m2.cd-1.s-3) and td (timing delay, msec) parameters. (B) Rod bipolar cell function (mean ± SEM) can be assayed by modelling the intensity response series of the rod PII (unfilled circles ○) with a Naka-Rushton function (grey line). This returns Vmax (saturated amplitude, µV), k (1/sensitivity, log cd s m-2) and n (slope). (C) Retinal ganglion cell function is assayed at dim luminous energies and quantified by pSTR peak amplitude (pSTRamp) and timing (pSTRit). (D) Cone bipolar cell function is elicited with a paired-flash paradigm quantified by cone PII peak amplitude (cone PIIamp) and timing (cone PIIit). Please click here to view a larger version of this figure.
Figure 3. Group Average VEP Waveforms. The shape of the VEP waveform alters with increasing stimulus energy. Numbers to the left of the waveform indicate the luminous exposure used to elicit the waveform. Please click here to view a larger version of this figure.
Figure 4. VEP Analysis and Intensity Response Function. (A) Amplitude analysis of the VEP is taken as peak to trough (P1N1) and trough to peak (N1P2) amplitudes. The implicit times (it) of these responses is also returned (P1it, N1it, P2it). (B) The VEP P1N1 amplitude (mean ± SEM) increases with increasing stimulus energy. Please click here to view a larger version of this figure.
The ERG and VEP are objective measures of visual function from the retina and cortex, respectively. The advantage of simultaneous recording is that a more comprehensive view of the entire visual pathway is afforded. Specifically, the complementary information from their concurrent assessment could provide a clearer delineation of the site of injury in the visual pathway (e.g., for disorders with overlapping ERG yet distinct VEP manifestations18, when optic neuropathy may co-exist with primary cerebral atrophy19,20, or when VEP loss may be confounded by manifestation of injuries at several locations in visual pathway21,22). By measuring the ERG and VEP concurrently, an index of the gain between retinal and cortical response can also be derived. This may provide a useful tool to detect subtle pathological changes. The current protocol allows for ERG and VEP measurement in commonly used laboratory rats but can readily be adapted to other mammalian species23-25. ERG and VEP waveforms from rodents provide a reasonable preclinical surrogate for responses observed in human eyes26-28.
By designing a specific stimulus protocol, both ERG and VEP response can be obtained during a single recording session. Table 1 shows a progression in light levels with appropriate consideration of the recovery time between consecutive flashes. This protocol provides a balance between the need to maximize signal-to-noise characteristics and to limit recording time within the anesthetic window provided by a single dose of ketamine:xylazine. Therefore, this technique may be useful for an objective quantitative measure of visual function for research into basic physiology and disease.
A comprehensive assessment of the visual system can be achieved by concurrently assessing bilateral retinal responses and visually evoked cortical responses. However, each technique can also be conducted in isolation and monocularly instead of binocularly to simplify the procedure. The current protocol describes scotopic ERG and VEP signals chosen to isolate the rod-pathway given that rats have a rod-dominated retina. If light adapted responses are of greater interest to the study, it is also possible to conduct photopic ERG and VEP signals by pre-adaption to a background light.
One major limitation of this technique is the need to conduct the procedure under anaesthetized conditions to enable stable electrode placement. Nevertheless this approach provides robust signal-to-noise characteristics enabling detection of subtle treatment changes.
Due to the small amplitude of the STR and its sensitivity to light adaptation, several steps need to be closely observed to ensure successful recording of this response. Firstly, sufficient dark adaptation needs to be implemented, which includes overnight dark adaptation (≥ 8 hr), electrode placement under dim red lighting (17.4 cd.m-2, λmax = 600 nm), and re-dark adaptation following a dim test-flash (10 min for – 0.52 log cd.s.m-2). Furthermore, the signal-to-noise characteristics of the STR can be improved by averaging over multiple signals (i.e., 20 signals) collected with short inter-stimulus intervals (i.e., 2 sec). One of the advantages of this comprehensive assessment of both eyes and cortices is to enable comparison to the contralateral recording3. As such, particular care should be taken in electrode making (i.e., same sized and shaped electrodes), to ensure minimal inter-eye and inter-cortical variability.
Given the extensive usage of both ERG and VEP techniques to provide in vivo measures of the visual pathway and its disease-related processes, it would be useful to collate other pathway-specific protocols (e.g., ON/OFF or cone sub-type specific), and perform simultaneous ERG/VEP recordings with different stimulus modalities (e.g., flicker, pattern, sawtooth) to extend the application of this technique in clinical diagnoses. Another logical step of this application in the future would also be to record the ERG and VEP concurrently from conscious29, freely-moving animals to avoid anesthetic influences on neural physiology30.
The authors have nothing to disclose.
Funding for this project was provided by the National Health and Medical Research Council (NHMRC) 1046203 (BVB, AJV) and Melbourne Neuroscience Institute Fellowship (CTN).
Alligator clip | generic brand | HM3022 | Stainless steel 26 mm clip for connecting VEP screw electrodes to cables |
Bioamplifier | ADInstruments | ML 135 | For amplifying ERG and VEP signals |
Carboxymethylcellulose sodium 1.0% | Allergan | CAS 0009000-11-7 | Viscous fluid for improving signal quality of the active ERG electrode |
Carprofen 0.5% | Pfizer Animal Health Group | CAS 53716-49-7 | Proprietary name: Rimadyl injectable (50 mg/mL). For post-surgery analgesia, diluted to 0.5% (5 mg/mL) in normal saline |
Chlorhexadine 0.5% | Orion Laboratories | 27411, 80085 | For disinfecting surgical instruments |
Circulating water bath | Lauda-Königshoffen | MGW Lauda | For maintaining body temperature of the anesthetized animal during surgery and electrophysiological recordings |
Dental amalgam | DeguDent GmbH | 64020024 | For encasing the electrode-skull assembly to make it more robust |
Dental burr | Storz Instruments, Bausch and Lomb | #E0824A | A miniature drill head of ~0.7mm diameter for making a small hole in the skull over each hemisphere to implant VEP screws |
Drill | Bosch | Dremel 300 series | An automatic drill for trepanning |
Electrode lead | Grass Telefactor | F-E2-30 | Platinum cables for connecting silver wire electrodes to the amplifier |
Faraday Cage | custom-made | Ensures light proof to maintain dark adaptation. Encloses the Ganzfeld setup to improve signal to noise ratio | |
Gauze swabs | Multigate Medical Products Pty Ltd | 57-100B | For drying the surgical incision and exposed skull surface during surgery |
Ganzfeld integrating sphere | Photometric Solutions International | Custom designed light stimulator: 36 mm diameter, 13 cm aperture size | |
Velcro | VELCRO Australia Pty Ltd | VELCRO Brand Reusable Wrap | Hook-and-loop fastener to secure the electrodes and the animal on the recording platform |
Isoflurane 99.9% | Abbott Australasia Pty Ltd | CAS 26675-46-7 | Proprietary Name: Isoflo(TM) Inhalation anaaesthetic. Pharmaceutical-grade inhalation anesthetic mixed with oxygen gas for VEP electrode implant surgery |
Ketamine | Troy Laboratories | Ilium Ketamil | Proprietary name: Ketamil Injection, Brand: Ilium. Pharmaceutical-grade anesthetic for electrophysiological recording |
Luxeon LEDs | Phillips Lighting Co. | For light stimulation twenty 5 watt and one 1 watt LEDs. | |
Micromanipulator | Harvard Apparatus | BS4 50-2625 | Holds the ERG active electrode during recordings |
Needle electrode | Grass Telefactor | F-E2-30 | Subcutaneously inserted in the tail to serve as the ground electrode for both the ERG and VEP |
Phenylephrine 2.5% minims | Bausch and Lomb | CAS 61-76-7 | Instilled with Tropicamide to achieve maximal dilation for ERG recording |
Povidone iodine 10% | Sanofi-Aventis | CAS 25655-41-8 | Proprietory name: Betadine, Antiseptic to prepare the shaved skin for surgery 10%, 500 mL |
Powerlab data acquisition system | ADInstruments | ML 785 | Controls the LEDs |
Proxymetacaine 0.5% | Alcon Laboratories | CAS 5875-06-9 | For corneal anaesthesia during ERG recordings |
Saline solution | Gelflex | Non-injectable, for electroplating silver wire electrodes | |
Scope Software | ADInstruments | version 3.7.6 | Simultaneously triggers the stimulus via the Powerlab system and collects data |
Silver (fine round wire) | A&E metal | 0.3 mm | Used to make active and inactive ERG electrodes, and the inactive VEP electrode |
Stainless streel screws | MicroFasterners | 0.7 mm shaft diameter, 3 mm in length to be implanted over the primary visual cortex and serve as the active VEP electrodes | |
Stereotaxic frame | David Kopf | Model 900 | A small animal stereotaxic instrument for locating the primary visual cortices according to Paxinos & Watson's 2007 rat brain atlas coordinates |
Surgical blade | Swann-Morton Ltd. | 0206 | For incising the area of skin overlaying the primary visual cortex to implant the VEP electrodes |
Suture | Shanghai Pudong Jinhuan Medical Products Co.,Ltd | 3-0 silk braided suture non-absorbable, for skin retraction during VEP electrode implantation surgery | |
Tobramycine eye ointment 0.3% | Alcon Laboratories | CAS 32986-56-4 | Proprietary name: Tobrex. Prophylactic antibiotic ointment applied around the skin wound after surgery |
Tropicamide 0.5% | Alcon Laboratories | CAS 1508-75-4 | Proprietary name: 0.5% Mydriacyl eye drop, Instilled to achieve mydriasis for ERG recording |
Xylazine | Troy Laboratories | Ilium Xylazil-100 | Pharmaceutical-grade anesthetic for electrophysiological recording |
Pipette tip | Eppendorf Pty Ltd | 0030 073.169 | Eppendorf epTIPS 100 – 5000 mL, for custom-made electrodes |
Microsoft Office Excel | Microsoft | version 2010 | spreadsheet software for data analysis |
Lethabarb Euthanazia Injection | Virbac (Australia) Pty Ltd | LETHA450 | 325 mg/mL pentobarbital sodium for rapid euthanazia |